G1 Therapeutics And Pepper Bio Announced A Global Licensing Agreement (Excluding The Asia-Pacific Region) For Lerociclib For All Indications Except For Certain Radioprotectant Uses
G1 Therapeutics And Pepper Bio Announced A Global Licensing Agreement (Excluding The Asia-Pacific Region) For Lerociclib For All Indications Except For Certain Radioprotectant Uses
G1 Therapeutics和Pepper Bio宣布了Lerociclib的全球许可协议（不包括亚太地区），用于除某些放射防护剂用途以外的所有适应症
G1 Therapeutics And Pepper Bio Announced A Global Licensing Agreement (Excluding The Asia-Pacific Region) For Lerociclib For All Indications Except For Certain Radioprotectant Uses
G1 Therapeutics和Pepper Bio宣布了Lerociclib的全球许可协议（不包括亚太地区），用于除某些放射防护剂用途以外的所有适应症
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。